Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK

Development and Validation of Nomograms for Predicting Pneumonia in Patients with COVID-19 and Lung Cancer

“… 7 Radiation may injure normal lung tissue and radiotherapy enhances the rate of pneumonia after SARS-CoV-2 infection. 8 , 9 At present, there is still a lack of safe and effective therapeutic drugs for COVID-19 in the clinic. Once lung cancer patients develop COVID-19 pneumonia, the poor response to conventional therapy will make condition difficult to control and threaten patients’ life.…”